Early research (Phase 1)UnknownNCT05302843What this trial is testingBPI-28592 in Subjects With Advanced Solid TumorsWho this might be right forMetastasis, Neoplasm Betta Pharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT01051635What this trial is testingA Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and LymphomasWho this might be right forNeoplasmsLymphoma National Cancer Institute (NCI) 55
Early research (Phase 1)Ended earlyNCT04835714What this trial is testingFind a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])Who this might be right forSolid Tumors, KRAS Mutation Boehringer Ingelheim 8
Early research (Phase 1)Study completedNCT04330664What this trial is testingAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 86
Early research (Phase 1)Study completedNCT01919398What this trial is testingLY2940680 in Japanese Participants With Advanced CancersWho this might be right forNeoplasm Metastasis Eli Lilly and Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT05970016What this trial is testingA Phase I/II Clinical Study in Patients with Advanced Solid Tumor.Who this might be right forPatients with Advanced Solid Tumors Beijing Tide Pharmaceutical Co., Ltd 56
Early research (Phase 1)Study completedNCT03133247What this trial is testingA Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer PatientsWho this might be right forAdvanced Solid Tumors Atridia Pty Ltd. 37
Early research (Phase 1)Study completedNCT00165802What this trial is testingA Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid TumorsWho this might be right forCancer, Malignant Tumors Eisai Inc. 40
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Testing effectiveness (Phase 2)Study completedNCT00526045What this trial is testingPhase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsWho this might be right forBreast CancerHematologic Neoplasms Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872What this trial is testingStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsWho this might be right forSolid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more Cybrexa Therapeutics 130
Early research (Phase 1)Ended earlyNCT01378377What this trial is testingCombination Trial of Pimasertib (MSC1936369B) With TemsirolimusWho this might be right forAdvanced Solid Tumor EMD Serono 33
Early research (Phase 1)Study completedNCT03077607What this trial is testingEvaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Pfizer 36
Early research (Phase 1)Study completedNCT00003207What this trial is testingLiposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersWho this might be right forSarcomaUnspecified Adult Solid Tumor, Protocol Specific Washington University School of Medicine 14
Early research (Phase 1)Study completedNCT04094506What this trial is testingStudy of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid TumorsWho this might be right forLocally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Astellas Pharma Inc 9
Early research (Phase 1)Study completedNCT02004106What this trial is testingEvaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid TumorsWho this might be right forNeoplasms Hoffmann-La Roche 110
Early research (Phase 1)Study completedNCT00162136What this trial is testingClinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.Who this might be right forSolid Malignancies R-Pharm 35
Early research (Phase 1)Study completedNCT05501821What this trial is testingStudy of KBA1412 in Participants With Advanced Solid Malignant TumorsWho this might be right forAdvanced Solid Tumor Malignancy Kling Biotherapeutics B.V. 16
Early research (Phase 1)Study completedNCT06012708What this trial is testingPhase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713Who this might be right forAdvanced Solid Tumors New Cancer Cure-Bio Co.,Ltd. 12
Early research (Phase 1)UnknownNCT04325711What this trial is testingCSPCHA131 in Patients With Advanced Solid TumorWho this might be right forAdvanced Solid Tumors CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 100